Results 111 to 120 of about 501,321 (365)
Risk of hepatocellular carcinoma in untreated patients with chronic hepatitis B: Independent of HBeAg status? [PDF]
Ho Soo Chun, Minjong Lee
doaj +1 more source
Inability to Detect Hepatitis B Virus or Specific Antigens in Transformed Chimpanzee Lymphocytes [PDF]
Charles A. Schable+4 more
openalex +1 more source
B cells and systemic sclerosis interstitial lung disease
Interstitial lung disease is an important complication of systemic sclerosis (SSc‐ILD) with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to FDA‐approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of interstitial lung diseases of other systemic autoimmune ...
Nina Goldman+2 more
wiley +1 more source
Hepatitis B antigen in black patients with hepatocellular carcinoma.Correlation between orcein stained liver sections and serology [PDF]
Cynthia Cohen+2 more
openalex +1 more source
Abstract Background Tumor‐associated neutrophils (TANs) play a critical role in modulating immune responses and exhibit significant heterogeneity. Our previous study demonstrated that jagged canonical Notch ligand 2 (JAG2)+ TANs were associated with an immunosuppressive microenvironment in high‐grade serous ovarian cancer (HGSOC), but the underlying ...
Chenyang Wang+11 more
wiley +1 more source
The immune response to hepatitis B surface antigen (HBsAg) is influenced by several factors, of which HLA antigens and balanced secretion of Th1/Th2 cytokines play important roles.
Abdollah Jafarzadeh, Fazel Shokri
doaj
The problem of the demonstration of hepatitis B antigen in faeces and bile [PDF]
J. W. Moodie+2 more
openalex +1 more source
Abstract Background Hepatocellular carcinoma (HCC) is a deadly malignancy known for its ability to evade immune surveillance. NOP2/Sun RNA methyltransferase family member 2 (NSUN2), an RNA methyltransferase involved in carcinogenesis, has been associated with immune evasion and energy metabolism reprogramming.
Jinhua Jiang+6 more
wiley +1 more source
Abstract Background The ASTRUM‐005 study previously demonstrated a significant overall survival (OS) benefit with serplulimab (a programmed death 1 inhibitor) plus chemotherapy versus chemotherapy alone in previously untreated extensive‐stage small‐cell lung cancer (ES‐SCLC).
Ying Cheng+32 more
wiley +1 more source
Solid-phase enzyme immunoassay for hepatitis B surface antigen. [PDF]
R Wei+3 more
openalex +1 more source